Jefferies Group LLC Regenxbio Inc. Transaction History

Jefferies Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$24.62 - $34.31 $268,111 - $373,635	-10,890 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$30.19 - $40.28 $328,769 - $438,649	10,890 New	10,890 $153,000
Q3 2019 Nov 13, 2019	SELL	$31.84 - $50.88 $260,005 - $415,486	-8,166 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$42.0 - $59.29 $169,218 - $238,879	4,029 Added 97.39%	8,166 $419,000
Q1 2019 May 15, 2019	SELL	$40.82 - $62.45 $225,530 - $345,036	-5,525 Reduced 57.18%	4,137 $237,000
Q4 2018 Feb 14, 2019	BUY	$39.11 - $75.15 $377,880 - $726,099	9,662 New	9,662 $405,000

197

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $416M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.